Lumanity’s Post

"We need to optimise patient participation in relevant trials, to better address patient needs and limit the excessive number of inefficient clinical research programmes. EORTC is committed to improving access to cancer clinical trials in the EU.” - Dr. Denis Lacombe, EORTC CEO. We are proud to share that our CEO, Dr. Denis Lacombe, participated in an engaging panel today at the Economist Impact’s 9th annual World Cancer Series Europe about improving access to clinical trials. Learn more: https://lnkd.in/dCXTXrhp Economist Impact events #EconWorldCancerSeries #CancerResearch #ClinicalTrials #Ocnology #Cancer

On this Clinical Trials Day, we celebrate the scientists, researchers and healthcare professionals who make clinical trials possible … Today, we reiterate the unwavering commitment of our teams at King Hussein Cancer Foundation and Center towards patients and their families; easing pain and providing life-saving treatments through breakthrough research and clinical trials … ACRP - Association of Clinical Research Professionals King Hussein Cancer Foundation and Center #TrailblazersAmongUs #ACRP #ClinicalResearchSavesLives #TogetherWeExcel #CTD2024 #ClinicalTrialsDay

Listen to Episode 2 of the the Big Ten Cancer Research Consortium podcast, Bridging the Gap. Our Cancer Center member Ryan Nguyen, a UI Health medical oncologist, joined hosts Craig Cole, MD, of Michigan State University College of Human Medicine, Coral Omene, MD, PhD, of Rutgers Cancer Institute of New Jersey, and Monika Joshi, MD, MRCP, of PENN STATE MILTON S. HERSHEY MEDICAL CENTER, for an in-depth conversation on diversity in clinical trials. The group discussed a range of topics including barriers to equitable enrollment in clinical trials, the role of the FDA in promoting more diverse clinical trial enrollment, the role of precision oncology for diverse populations, findings from a clinical study on enrollment in trials leading to FDA approvals in breast cancer, community engagement in clinical trials, and the impact of lung cancer screening. https://bit.ly/3NfnvU8 #cancer #clinicaltrials #diversity #breastcancer #lungcancer

May is #NationalCancerResearchMonth. Because of the incredible advances made by #cancer researchers, over 18 million people in the U.S. are cancer survivors who are living with, through and beyond their disease, but there is still work to be done. Imvax is working to tackle solid tumor cancers with personalized immunotherapies that are designed to provide meaningful improvements in patient outcomes. Learn more about #IGV001, our lead program for #glioblastoma: https://bit.ly/4ayveGx #NCRM24 #CancerResearchSavesLives #CancerResearch

🎉 2023 has been an extraordinary year for #cancerresearch. It's been exciting to watch the evolution of treatments and technologies, empowering us to wage a stronger fight against #cancer. Cancer Research UK (CRUK) has compiled a list of 5 transformative innovations of the past year. 👇 1️⃣ A game-changing development from the remarkable team at The University of Sheffield, who have engineered a groundbreaking magnetic method to guide chemotherapies through the notoriously difficult blood-brain barrier to treat #braintumours. 🧠 2️⃣ Impressive strides continue with the University of Sheffield's promising use of oncolytic viruses within immune cells to improve cancer immunotherapy. 🦠 As proud collaborators with The University of Sheffield, at Physiomics plc, we're committed to fostering innovation to advance life-saving treatments for cancer. For more insights on 2023's pivotal stories, visit: https://lnkd.in/eU2jG8rd #cancer #research #innovation #breastcancer #gliomas

Would’ve never thought M&Ms could be such a helpful analogy for understanding cancer research… but I was SO inspired as I listened to Dr. Michael Tolentino describe how simplifying complex problems like cancer and blindness can lead to breakthroughs in cures. It was a standout session at a recent GDS Group #LifeSciences summit, and I just knew more people would want to hear these analogies too. So, here’s my article on “Simplifying for a Cure: How M&M’s Could Help Scientists Cure Cancer” https://lnkd.in/dR2T2uFt #lifesciencesinnovation #cancerresearch #blindingdiseases

🚀 You're Invited: Breakthrough Breakfast: Pioneering Possibilities in Cancer Research! On June 18th, I will be attending Dalhousie's Faculty of Medicine's Breakthrough Breakfast: Pioneering Possibilities in Cancer Research. This event promises to be an exciting look at the ongoing battle against cancer, highlighting the incredible research advancements being made in the field - right here in Nova Scotia. The highly personalized form of immunotherapy called CAR-T therapy that is happening in our own backyard is not just changing lives, but is redefining the future of cancer treatment. The fact that blood cancers, and one day solid tumours, can be treated with fewer side-effects than other therapies is a game-changer for cancer patients. Every breakthrough brings us one step closer to more effective treatments and, ultimately, cures. Events like this provide invaluable opportunities to learn, share, and support the remarkable efforts of researchers and medical professionals at Dal's Faculty of Medicine. I'm proud to be part of this exciting work - even if it's just helping spread the word about it! I look forward to attending and hope to see you there! #CancerResearch #CAR_Therapy #MedicalInnovation #DalhousieMedicine #BreakthroughBreakfast #FutureOfMedicine #HealthcareInnovation

By combining their training, experience, and research acumen with the power of real world data to publish new findings, oncologists like Ainhoa Madariaga and Luis Manso of Hospital 12 de Octubre help more cancer survivors than they will ever meet. Congratulations Drs. Madariaga and Manso on the selection of your research, "Association between endometriosis and ovarian cancer prognosis: A Real World Data Study" as one of the top four communications at the 2023 Congress of the Sociedad Española de Oncología Médica (SEOM). If you are attending, don't miss the Plenary Session presentation on Friday, September 22. See first comment for the link. #endometriosis #ovariancancer #realworlddata #realworldevidence #medicaloncology

Don't miss the 3rd DKFZ German Cancer Research Center German #Cancer Research Congress starting today! And if you are interested, refresh how we used #AI to predict the severity signature of diverse cancer samples in our paper: "A Data Science Approach for the Identification of Molecular Signatures of Aggressive Cancers" https://lnkd.in/ePgitCJh #machinelearning #science #deeplearning